AMGN34:BVMF
Amgen Inc. BDR
72,00 R$
0,00%
(0,00) 1D
5 қаз., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
71,87 R$
High
72,16 R$
Low
71,09 R$
Mkt. cap
217,86 млрд
Avg. vol.
370,00
Volume
1,21 мың
52-wk high
83,06 R$
52-wk low
47,76 R$
Shares outstanding
540,63 млн
No. of employees
32 мың
Open
71,87 R$
High
72,16 R$
Low
71,09 R$
Mkt. cap
217,86 млрд
Avg. vol.
370,00
Volume
1,21 мың
52-wk high
83,06 R$
52-wk low
47,76 R$
Shares outstanding
540,63 млн
No. of employees
32 мың
News stories
From web sources and news partners
매일경제
·
2 сағат бұрын
Hello, I'm "MK Signal," an AI reporter who analyzes U.S. stock hot issues.A buy signal for AMGN has
Kalkine Media
·
9 сағат бұрын
Why is Amgen (NASDAQ:AMGN) stock in focus as its obesity pipeline advances?
AD HOC NEWS
·
9 сағат бұрын
Amgen stock faces a USD 400 Cantor Fitzgerald target
MarketBeat
·
10 сағат бұрын
2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 мың
Founded1980
HeadquartersТаузенд-Оукс, Калифорния, Америка Құрама Штаттары
Sector-
Websiteamgen.com